> Detailanzeige
Goldschagg, Nicolina;
Teupser, Daniel;
Feil, Katharina;
Strupp, Michael
No evidence for a specific vitamin D deficit in benign paroxysmal positional vertigo
Teilen
Literatur-
verwaltung
Direktlink
Zur
Merkliste
Lösche von
Merkliste
Per Email teilen
Auf Twitter teilen
Auf Facebook teilen
Per Whatsapp teilen
- Medientyp: E-Artikel
- Titel: No evidence for a specific vitamin D deficit in benign paroxysmal positional vertigo
- Beteiligte: Goldschagg, Nicolina; Teupser, Daniel; Feil, Katharina; Strupp, Michael
- Erschienen: Wiley, 2021
- Erschienen in: European Journal of Neurology
- Umfang: 3182-3186
- Sprache: Englisch
- DOI: 10.1111/ene.14980
- ISSN: 1351-5101; 1468-1331
- Schlagwörter: Neurology (clinical) ; Neurology
- Zusammenfassung: <jats:title>Abstract</jats:title><jats:sec><jats:title>Background and purpose</jats:title><jats:p>The aim was to investigate whether there is a difference in serum 25‐hydroxyvitamin D (25(OH)D) concentration between patients with benign paroxysmal positional vertigo (BPPV), patients with other vestibular diseases and patients with other neurological non‐vestibular diseases presenting in a tertiary neurological academic outpatient clinic.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The serum 25(OH)D concentration was measured in 680 patients (368 male, mean age ± SD 58 ± 17 years, 661 Caucasian) without vitamin D supplementation. 158 patients had BPPV; 221 had other vestibular diseases (including 122 with peripheral vestibular disorders, such as unilateral vestibulopathy or Ménière's disease; 46 with central vestibular disorders, such as vestibular migraine or cerebellar dizziness; 53 with functional dizziness); and 301 patients with other neurological non‐vestibular diseases.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There was no significant difference in the serum 25(OH)D concentration between patients with BPPV (mean ± SD 23.4 ± 9.4 ng/ml) and those with other vestibular disorders (24.9 ± 10.1 ng/ml, <jats:italic>p</jats:italic> = 0.324). Patients with other neurological disorders had even lower concentrations (21.4 ± 10.6 ng/ml) than patients with BPPV (<jats:italic>p</jats:italic> < 0.005), patients with other vestibular disorders (<jats:italic>p</jats:italic> < 0.005) and all patients with vestibular disorders (24.9 ± 10.1 ng/ml, <jats:italic>p</jats:italic> < 0.005).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our analysis does not support the theory of a specific relationship between serum 25(OH)D concentration and the occurrence of BPPV or other vestibular disorders.</jats:p></jats:sec>
- Beschreibung: <jats:title>Abstract</jats:title><jats:sec><jats:title>Background and purpose</jats:title><jats:p>The aim was to investigate whether there is a difference in serum 25‐hydroxyvitamin D (25(OH)D) concentration between patients with benign paroxysmal positional vertigo (BPPV), patients with other vestibular diseases and patients with other neurological non‐vestibular diseases presenting in a tertiary neurological academic outpatient clinic.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The serum 25(OH)D concentration was measured in 680 patients (368 male, mean age ± SD 58 ± 17 years, 661 Caucasian) without vitamin D supplementation. 158 patients had BPPV; 221 had other vestibular diseases (including 122 with peripheral vestibular disorders, such as unilateral vestibulopathy or Ménière's disease; 46 with central vestibular disorders, such as vestibular migraine or cerebellar dizziness; 53 with functional dizziness); and 301 patients with other neurological non‐vestibular diseases.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There was no significant difference in the serum 25(OH)D concentration between patients with BPPV (mean ± SD 23.4 ± 9.4 ng/ml) and those with other vestibular disorders (24.9 ± 10.1 ng/ml, <jats:italic>p</jats:italic> = 0.324). Patients with other neurological disorders had even lower concentrations (21.4 ± 10.6 ng/ml) than patients with BPPV (<jats:italic>p</jats:italic> < 0.005), patients with other vestibular disorders (<jats:italic>p</jats:italic> < 0.005) and all patients with vestibular disorders (24.9 ± 10.1 ng/ml, <jats:italic>p</jats:italic> < 0.005).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our analysis does not support the theory of a specific relationship between serum 25(OH)D concentration and the occurrence of BPPV or other vestibular disorders.</jats:p></jats:sec>
- Anmerkungen: